MODY (Maturity-Onset Diabetes of the Young) is a monogenic (single-gene) form of diabetes, inherited in an autosomal dominant pattern. Unlike classic type 1 (autoimmune) or typical type 2 (insulin resistance-driven), MODY results from a gene defect that impairs beta-cell function. Many patients are misclassified for years, which matters because the outlook and the approach to care differ by gene.

When should you suspect MODY?

  1. Think MODY in a person with:
  2. Diabetes diagnosed
  3. Non-obese or only mildly overweight (BMI often normal/near-normal)
  4. No ketosis or DKA despite years of disease
  5. Good control on low-dose oral therapy (sometimes diet alone)
  6. Negative autoantibodies (GAD, IA-2, ZnT8) and preserved C-peptide
  7. Family history of diabetes across ?2 generations (autosomal dominant pattern)

Exam/clinic pearl: If a lean 20- or 30-something is still making insulin (C-peptide preserved), has never had DKA, and doesn’t look insulin-resistant—pause and consider MODY.

Why genetic testing changes everything

Confirms the diagnosis (prevents years of misclassification).

Clarifies the outlook: different genes behave differently, and some forms, such as GCK-MODY, cause mild, stable hyperglycaemia.

Guides family screening: autosomal dominant ? test first-degree relatives.

Matters in pregnancy, when the genetic diagnosis affects antenatal care.

Which test to order? Request a MODY gene panel, or if phenotype strongly fits, start with HNF1A. In primary care, start with antibodies and C-peptide to justify referral/testing:

Autoantibodies: negative

C-peptide: detectable/preserved (outside the honeymoon period)